FDAnews Drug Daily Bulletin Sign Up Now

May 20, 2022

View Archived Issues

Roche’s Faricimab Gains UK Approval Via International Program

The approval is the first MHRA granted under the collaborative program. Read More

Maine Joins Two Other States Considering Making Their Own Insulin

The commission will also examine the feasibility of providing the state-produced insulin to low-income residents. Read More

CanSino Biologics’ COVID-19 Vaccine Gets EUL From the WHO

The WHO is recommending the vaccine for people age 18 years and older. Read More

AbbVie Gains License Option to Cugene’s Autoimmune and Inflammatory Disease Portfolio

Under the terms of the agreement, Cugene will receive an upfront payment of $48.5 million, plus additional payments for reaching developmental or regulatory milestones. Read More

Upcoming Events

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More